Boothbay Fund Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $104,470 - $136,707	-24,239 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $124,103 - $165,309	24,239 New	24,239 $124,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $387,324 - $603,049	-81,714 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $322,770 - $442,889	81,714 New	81,714 $373,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $102,217 - $152,171	-28,875 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $12,269 - $23,341	4,275 Added 17.38%	28,875 $137,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $78,296 - $170,279	-31,828 Reduced 56.4%	24,600 $86,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $149,534 - $313,739	56,428 New	56,428 $272,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.